Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer

We aimed to identify a panel of circulating plasma microRNAs that can predict EGFR mutation status and monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with non-small cell lung cancer. Microarrays were performed for the preliminary screening of dysregulated mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Lili, Li, Liangliang, Zheng, Xiaofei, Fu, Hanjiang, Tang, Chuanhao, Qin, Haifeng, Li, Xiaoyan, Wang, Hong, Li, Jianjie, Wang, Weixia, Yang, Shaoxing, Wang, Lin, Zhao, Guanhua, Lv, Panpan, Lei, Yangyang, Zhang, Min, Gao, Hongjun, Song, Santai, Liu, Xiaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542229/
https://www.ncbi.nlm.nih.gov/pubmed/28496005
http://dx.doi.org/10.18632/oncotarget.17416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542229/
https://www.ncbi.nlm.nih.gov/pubmed/28496005
http://dx.doi.org/10.18632/oncotarget.17416

Ejemplares similares